ABS-CBN
New Health chief eyes getting more COVID bivalent vaccines
Newly appointed Health Secretary Teodoro Herbosa announced the Department of Health's (DOH) intention to secure additional supplies of COVID-19 bivalent vaccines.
The Philippines received its first batch of 400,000 bivalent vaccines against the coronavirus, donated by the Lithuanian government.
Herbosa mentioned that the government is coordinating with the World Health Organization (WHO), the COVAX facility, and UNICEF to obtain more bivalent vaccines.
He emphasized the need to procure more bivalent vaccines, especially for vulnerable populations and healthcare workers whose previous vaccinations may be waning.
Herbosa also noted that President Ferdinand Marcos Jr. ordered him to draft a COVID-19 exit plan for the Philippines.
Topics in this story
Explore more stories about these topics.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.
The Philippines received over 390,000 doses of Pfizer bivalent COVID-19 vaccines donated by the Lithuanian government, marking the country's first delivery of such vaccines.
+2
Read more →
Health Secretary Teodoro Herbosa urged local government units (LGUs) to immediately administer bivalent COVID-19 vaccines, which expire in November.
+1
Read more →
The Department of Health (DOH) is procuring more bivalent vaccines against COVID-19 as the initial supply is insufficient for the entire Filipino population.
Read more →
An infectious diseases expert expressed hope that the Philippines would secure an adequate supply of bivalent COVID-19 vaccines, particularly for healthcare workers and vulnerable populations.
Read more →
The Ilocos region has received 23,460 doses of Pfizer-manufactured bivalent COVID-19 vaccines, which offer protection against the Omicron variant.
Read more →